{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:44:16Z","timestamp":1794282256644,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.smrv.2021.101573","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:47:37Z","timestamp":1637880457000},"page":"101573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"61","author":[{"given":"Tao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeya","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-0845","authenticated-orcid":false,"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.smrv.2021.101573_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","article-title":"Insomnia","volume":"309","author":"Buysse","year":"2013","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.smrv.2021.101573_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5665\/SLEEP.1150","article-title":"Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS)","volume":"34","author":"Walsh","year":"2011","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.smrv.2021.101573_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biopsych.2010.10.023","volume":"69","author":"Roth","year":"2011","journal-title":"Biol Psychiatr"},{"issue":"5","key":"10.1016\/j.smrv.2021.101573_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archinternmed.2008.610","article-title":"The natural history of insomnia: a population-based 3-year longitudinal study","volume":"169","author":"Morin","year":"2009","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.smrv.2021.101573_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.5665\/SLEEP.1230","article-title":"Insomnia and the performance of US workers: results from the America insomnia survey","volume":"34","author":"Kessler","year":"2011","journal-title":"Sleep"},{"issue":"19","key":"10.1016\/j.smrv.2021.101573_bib6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/CIRCULATIONAHA.111.025858","article-title":"Insomnia and the risk of acute myocardial infarction: a population study","volume":"124","author":"Laugsand","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.smrv.2021.101573_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40266-018-0569-8","article-title":"Insomnia in elderly patients: recommendations for pharmacological management","volume":"35","author":"Abad","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.smrv.2021.101573_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2014.00016","article-title":"Hypocretin (orexin) regulation of sleep-to-wake transitions","volume":"5","author":"de Lecea","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.smrv.2021.101573_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/7854_2016_49","article-title":"Orexin\/hypocretin signaling","volume":"33","author":"Kukkonen","year":"2017","journal-title":"Curr Topic Behav Neurosci"},{"issue":"23","key":"10.1016\/j.smrv.2021.101573_bib10","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.smrv.2021.101573_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"Michelson","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.smrv.2021.101573_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol Psychiatr"},{"issue":"3","key":"10.1016\/j.smrv.2021.101573_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/alz.12035","article-title":"Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial","volume":"16","author":"Herring","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.smrv.2021.101573_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/clpt.2011.370","article-title":"Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial","volume":"91","author":"Hoever","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.smrv.2021.101573_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw034","article-title":"Dual orexin receptor antagonist, almorexant, in elderly patients with primary insomnia: a randomized, controlled study","volume":"40","author":"Roth","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2021.101573_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2017.05.009","article-title":"Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference","volume":"36","author":"Black","year":"2017","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.smrv.2021.101573_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw022","article-title":"A\u00a0phase II dose-ranging study evaluating the efficacy and safety of the orexin receptor antagonist filorexant (MK-6096) in patients with primary insomnia","volume":"19","author":"Connor","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.smrv.2021.101573_bib18","first-page":"1289","article-title":"Lemborexant, A dual orexin receptor antagonist (DORA) for the treatment of insomnia disorder: results from a Bayesian, adaptive, randomized, double-blind, placebo-controlled study","volume":"13","author":"Murphy","year":"2017","journal-title":"J\u00a0Clin Sleep Med : JCSM : Off Pub Am Acad Sleep Med"},{"issue":"12","key":"10.1016\/j.smrv.2021.101573_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and Zolpidem Tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/j.smrv.2021.101573_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","volume":"43","author":"K\u00e4rpp\u00e4","year":"2020","journal-title":"Sleep"},{"issue":"21","key":"10.1016\/j.smrv.2021.101573_bib21","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000009475","article-title":"Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder","volume":"94","author":"Zammit","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.smrv.2021.101573_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.25680","article-title":"Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder","volume":"87","author":"Dauvilliers","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2021.101573_bib23","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.smrv.2021.101573_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jch.13505","article-title":"Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: the SUPER-1 study","volume":"21","author":"Kario","year":"2019","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"3","key":"10.1016\/j.smrv.2021.101573_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5664\/jcsm.8220","article-title":"Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo","volume":"16","author":"Roehrs","year":"2020","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.smrv.2021.101573_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0269881118773745","article-title":"A\u00a0randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity","volume":"32","author":"De Boer","year":"2018","journal-title":"J\u00a0Psychopharmacol"},{"issue":"2","key":"10.1016\/j.smrv.2021.101573_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0269881118822258","article-title":"The selective orexin-2 receptor antagonist seltorexant improves sleep: an exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia","volume":"33","author":"Brooks","year":"2019","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.smrv.2021.101573_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41398-019-0553-z","article-title":"The selective orexin-2 antagonist seltorexant (JNJ-42847922\/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder","volume":"9","author":"Recourt","year":"2019","journal-title":"Transl Psychiatr"},{"issue":"2","key":"10.1016\/j.smrv.2021.101573_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M15-1781","article-title":"Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American college of physicians","volume":"165","author":"Wilt","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.smrv.2021.101573_bib30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs","volume":"22","author":"Buscemi","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.smrv.2021.101573_bib31","first-page":"CD010753","article-title":"Antidepressants for insomnia in adults","volume":"5","author":"Everitt","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.smrv.2021.101573_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","article-title":"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders","volume":"34","author":"Auld","year":"2017","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2021.101573_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smrv.2016.09.004","article-title":"Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis","volume":"35","author":"Kuriyama","year":"2017","journal-title":"Sleep Med Rev"},{"issue":"21","key":"10.1016\/j.smrv.2021.101573_bib34","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1016\/j.bmc.2014.08.034","article-title":"Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists","volume":"22","author":"Yoshida","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.smrv.2021.101573_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","article-title":"Lemborexant: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2021.101573_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2020.05.025","article-title":"Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis","volume":"128","author":"Kishi","year":"2020","journal-title":"J\u00a0Psychiatr Res"},{"issue":"2","key":"10.1016\/j.smrv.2021.101573_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm1544","article-title":"Promotion of sleep by targeting the orexin system in rats, dogs and humans","volume":"13","author":"Brisbare-Roch","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.smrv.2021.101573_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0333102414544979","article-title":"Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis","volume":"35","author":"Chabi","year":"2015","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.smrv.2021.101573_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AJP.0000000000000503","article-title":"Orexin receptor antagonism in painful diabetic neuropathy: a phase 2 trial with filorexant","volume":"34","author":"Joseph Herring","year":"2018","journal-title":"Clin J Pain"},{"issue":"8","key":"10.1016\/j.smrv.2021.101573_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ijnp\/pyx033","article-title":"Phase II proof-of-concept trial of the orexin receptor antagonist filorexant (MK-6096) in patients with major depressive disorder","volume":"20","author":"Connor","year":"2017","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079221001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079221001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:29:26Z","timestamp":1761067766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079221001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"alternative-id":["S1087079221001581"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2021.101573","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2021.101573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101573"}}